Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.33 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2838582 | 0.88 | MCHR1 (0.39) | SLC6A4HRH3MCHR1FPR2PROKR1 | |
| Hydrochloric Acid SCHEMBL2836932 | 0.83 | SLC6A4 (0.36) | SLC6A4HRH3SLC6A2 | |
| Hydrochloric Acid SCHEMBL2835799 | 0.79 | SLC9A3 (0.38) | SLC6A4HRH3PTGS2 | |
| Hydrochloric Acid SCHEMBL2839559 | 0.79 | SLC6A4 (0.36) | SLC6A4HRH3SLC6A2FPR2PROKR1 | |
| Hydrochloric Acid SCHEMBL3580232 | 0.79 | SLC6A2 (0.31) | SLC6A4SLC6A2 | |
| Hydrochloric Acid SCHEMBL2841523 | 0.79 | SLC6A2 (0.38) | SLC6A4HRH3SLC6A2FPR2PROKR1 | |
| Hydrochloric Acid SCHEMBL2835058 | 0.76 | AR (0.34) | — | |
| Hydrochloric Acid SCHEMBL3579144 | 0.76 | MCHR1 (0.33) | MCHR1 | |
| Hydrochloric Acid SCHEMBL2844337 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL2837907 | 0.76 | SMN1; SMN2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217031-B2 | Heteroaryl derivatives | NIPPON SHINYAKU CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100048537-A1 | HETEROARYL DERIVATIVES | NIPPON SHINYAKU CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2141168-A1 | HETEROARYL DERIVATIVES | Nippon Shinyaku Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048537-A1 | HETEROARYL DERIVATIVES | OPRD1, OPRM1, OPRK1 | SLC6A4 185/4885HRH3 777/4885MCHR1 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.